KRAS and neoplasm: All these results could have a potential biological rationale because of the correlation between a higher incidence of KRAS mutations in smokers and, as already known, the elevated rate of tumoral DNA mutations and the higher tumor mutational burden (TMB) in smoker patients compared to never-smokers (41, 42).